AlphaClone

This blog is dedicated to educating investors on how to intelligently follow hedge fund 13F filings and to establishing an ongoing conversation with our users and clients.

  • Home
  • Financial Professional
  • Do-It-Yourself Investor
  • Individual Investor

Categories

  • Start Here
  • Clone vs. Fund
  • Core Strategies
  • New Features
  • Performance
  • Press
  • Research Articles

Search

Recent Posts

  • Core Strategy Win/Loss Analysis 2011 & 2012
  • Loud Mouth Stocks
  • AlphaClone and Portfolio Fit
  • Clone Madness: Championship
  • Clone Madness: Final Four Results
  • Clone Madness: Quarter-final Results
  • Clone Madness: First Round
  • Clone Madness
  • AlphaClone Hedge Fund Long/Short Index - Sector Breakdowns for Q4 2012
  • 5 Most Bought/Sold Stocks in Q4 2012 Amongst AlphaClone's Hedge Fund Universe

ValueAct Holdings

Founded by Jeffrey Ubben in 2000, ValueAct Holdings is known for being activist investors. The firm buys large stakes in undervalued companies and works with their management to improve performance.

Follow

  • LinkedIn LinkedIn: mjadallah
  • Twitter Twitter: AlphaClone
Subscribe to this blog's feed

© 2013, AlphaClone LLC, All Rights Reserved. The AlphaClone logo is a service mark of AlphaClone LLC.

AlphaClone LLC is a research and investment management firm that tracks hedge funds and on behalf of its clients, invests in equity strategies based on hedge fund public disclosures. As such, the firm may currently hold stocks within client accounts that are highlighted within articles published on this blog. Investing in financial markets involves risk, including the risk of principal loss. Information on this blog is in no way intended as investment advice and should not be interpreted as such. Backtesting is the process of evaluating a core strategy by applying it to historical data. Backtested performance results are provided for purposes of illustrating historical performance had a core strategy had been available during the relevant period. Backtested performance results are hypothetical and have inherent limitations. AlphaClone makes no representation that any core strategy will achieve performance similar to any backtested performance results. Actual results could differ materially from backtested performance and future results could differ materially from backtested performance. Past performance is no indication or guarantee of future results. AlphaClone does not represent that backtested performance information is accurate, complete or current, and AlphaClone has no liability with respect thereto. The AlphaClone core strategies are subject to changewithout notice and AlphaClone has no obligation to update y ou as to any such changes. The information provided herein comes from what AlphaClone believes to be reliable sources. AlphaClone, however, makes no representations as to its reliability or accuracy, and you should undertake independent analysis to ensure the accuracy of the information. Please consult our Terms of Use for further information.